Status:
COMPLETED
EPO for Postop Delirium in Elderly Patients
Lead Sponsor:
Yonsei University
Conditions:
Postoperative Delirium
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
Postoperative delirium is a common complication after surgery. The underlying pathophysiology of this complication is unclear, however neuroinflammation and oxidative stress secondary to surgery had s...
Eligibility Criteria
Inclusion
- Age 65 years and older
- Patients scheduled for elective total knee arthroplasty, total hip arthroplasty
Exclusion
- Unable to communicate
- Cognitive impairment
- Unable to pre-screen delirium due to underlying central nervous system disease
- History of hypersensitivity related to erythropoietin and other anesthesia-related drugs
- History of myocardial infarction, pulmonary infarction, cerebral infarction, ischemic vascular disease, epilpesy, chronic liver disease, chronic kidney disease
- Uncontrolled high blood pressure
- Within one month of starting anti-hypertensive medication
Key Trial Info
Start Date :
September 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2019
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06178835
Start Date
September 12 2017
End Date
August 28 2019
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain medicine, Severance Hospital, Seoul, South Korea
Seoul, South Korea